CSX (CSX) – Research Analysts’ Weekly Ratings Updates

Share on StockTwits

A number of research firms have changed their ratings and price targets for CSX (NASDAQ: CSX):

  • 1/8/2019 – CSX is now covered by analysts at Atlantic Securities. They set an “overweight” rating and a $62.45 price target on the stock.
  • 1/8/2019 – CSX was given a new $75.00 price target on by analysts at Scotiabank. They now have a “hold” rating on the stock.
  • 1/7/2019 – CSX had its price target raised by analysts at Morgan Stanley from $55.00 to $56.00. They now have an “underweight” rating on the stock.
  • 1/7/2019 – CSX had its price target lowered by analysts at Credit Suisse Group AG from $86.00 to $79.00. They now have an “outperform” rating on the stock.
  • 1/4/2019 – CSX was downgraded by analysts at Wolfe Research from an “outperform” rating to a “market perform” rating.
  • 1/3/2019 – CSX was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $70.00 price target on the stock. According to Zacks, “Shares of CSX Corporation have outperformed its industry in a year's time. The company is benefiting from implementation of the Precision Scheduled Railroading system. Evidently, operating ratio has been declining steadily over the past few quarters owing to the company's cost cutting measures. We expect the metric to improve further in the fourth quarter of 2018, results of which will be out on Jan 16.   We are also positive on CSX's decision to raise its 2018 revenue growth guidance. The company now anticipates revenues to increase between 6% and 8% (previous guidance had predicted an increase in the mid-single digits). These apart, the company’s efforts to reward its shareholders through dividends and buybacks are also noteworthy. CSX's high debt levels, however, raise concerns.”
  • 1/2/2019 – CSX was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating.
  • 12/31/2018 – CSX had its price target lowered by analysts at Argus from $84.00 to $71.00. They now have a “buy” rating on the stock.
  • 12/18/2018 – CSX was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Shares of CSX Corporation have outperformed its industry in a year's time. The company is benefiting from implementation of the Precision Scheduled Railroading system. Evidently, operating ratio has been declining steadily over the past few quarters owing to the company's cost cutting measures. CSX's decision to raise its current-year revenue growth guidance is commendable as well. The company now anticipates revenues to increase between 6% and 8% (previous guidance had predicted an increase in the mid-single digits). These apart, the company’s efforts to reward its shareholders are noteworthy. CSX's high debt levels, however, raise concerns. Due to the stock's outperformance with respect to price over the past year, the valuation is by no means cheap now. The company will release fourth-quarter 2018 results on Jan 16.”
  • 12/17/2018 – CSX had its “buy” rating reaffirmed by analysts at Royal Bank of Canada. They now have a $82.00 price target on the stock.
  • 12/3/2018 – CSX had its price target raised by analysts at Deutsche Bank AG from $85.00 to $90.00. They now have a “buy” rating on the stock.

Shares of CSX traded up $0.07 during mid-day trading on Monday, hitting $65.29. 145,023 shares of the company’s stock were exchanged, compared to its average volume of 5,506,099. CSX Co. has a fifty-two week low of $48.43 and a fifty-two week high of $76.24. The company has a market capitalization of $54.03 billion, a price-to-earnings ratio of 28.39, a price-to-earnings-growth ratio of 1.14 and a beta of 1.33. The company has a debt-to-equity ratio of 1.00, a quick ratio of 1.29 and a current ratio of 1.43.

CSX (NASDAQ:CSX) last posted its quarterly earnings results on Tuesday, October 16th. The transportation company reported $1.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.94 by $0.11. The firm had revenue of $3.13 billion during the quarter, compared to analysts’ expectations of $3.05 billion. CSX had a net margin of 55.19% and a return on equity of 21.38%. The firm’s revenue for the quarter was up 14.1% on a year-over-year basis. During the same period in the prior year, the company posted $0.51 earnings per share. Equities research analysts forecast that CSX Co. will post 3.82 EPS for the current year.

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Visionary Asset Management Inc. purchased a new position in shares of CSX during the 4th quarter worth approximately $226,000. Cullinan Associates Inc. increased its stake in shares of CSX by 6.8% during the 4th quarter. Cullinan Associates Inc. now owns 37,770 shares of the transportation company’s stock worth $2,347,000 after purchasing an additional 2,400 shares in the last quarter. First Hawaiian Bank increased its stake in shares of CSX by 39.3% during the 4th quarter. First Hawaiian Bank now owns 9,738 shares of the transportation company’s stock worth $605,000 after purchasing an additional 2,746 shares in the last quarter. Highwater Wealth Management LLC purchased a new position in shares of CSX during the 4th quarter worth approximately $31,000. Finally, Moody National Bank Trust Division acquired a new stake in CSX during the fourth quarter worth approximately $34,000. 75.09% of the stock is owned by hedge funds and other institutional investors.

CSX Corporation, together with its subsidiaries, provides rail-based transportation services in the United States and Canada. The company offers rail services, as well as transports intermodal containers and trailers. It transports agricultural and food products, fertilizers, chemicals, automotive, metals and equipment, minerals, and forest products; and coal, coke, and iron ore to electricity-generating power plants, steel manufacturers, and industrial plants.

Read More: What are Institutional Investors?

Receive News & Ratings for CSX Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSX Co and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2019 BBNS.